ShockWave Medical Stock Income Statements

ShockWave Medical Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

ShockWave Medical Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31

revenue:
product revenue	202,979,000	186,020,000	180,165,000	161,066,000	144,026,000	131,330,000	120,746,000	93,631,000	84,183,000	65,155,000	55,908,000	31,900,000	22,716,000	19,590,000	10,286,000	15,197,000	14,312,000	11,333,000	10,012,000	7,269,000
yoy	40.93%	41.64%	49.21%	72.02%	71.09%	101.57%	115.97%	193.51%	270.59%	232.59%	443.53%	109.91%	58.72%	72.86%	2.74%	109.07%
qoq	9.12%	3.25%	11.86%	11.83%	9.67%	8.77%	28.96%	11.22%	29.20%	16.54%	75.26%	40.43%	15.96%	90.45%	-32.32%	6.18%	26.29%	13.19%	37.74%
cost of revenue:
cost of product revenue	25,316,000	24,513,000	24,493,000	21,066,000	17,502,000	17,874,000	16,730,000	12,890,000	12,663,000	10,949,000	9,934,000	7,892,000	6,471,000	5,277,000	3,592,000	5,651,000	5,553,000	4,401,000	4,133,000	3,072,000
gross profit	177,663,000	161,507,000	155,672,000	140,000,000	126,524,000	113,456,000	104,016,000	80,741,000	71,520,000	54,206,000	45,974,000	24,008,000	16,245,000	14,313,000	6,694,000	9,546,000
yoy	40.42%	42.35%	49.66%	73.39%	76.91%	109.31%	126.25%	236.31%	340.26%	278.72%	586.79%	151.50%
qoq	10.00%	3.75%	11.19%	10.65%	11.52%	9.08%	28.83%	12.89%	31.94%	17.91%	91.49%	47.79%	13.50%	113.82%	-29.88%
gross margin %	87.53%	86.82%	86.41%	86.92%	87.85%	86.39%	86.14%	86.23%	84.96%	83.20%	82.23%	75.26%	71.51%	73.06%	65.08%	62.82%	0%	0%	0%	0%
operating expenses:
research and development	42,321,000	39,526,000	36,829,000	26,971,000	23,723,000	20,177,000	20,760,000	17,019,000	14,717,000	13,735,000	11,815,000	10,277,000	9,044,000	7,891,000	8,101,000	11,890,000	10,075,000	8,368,000	6,926,000	7,484,000
sales and marketing	67,181,000	56,907,000	56,738,000	54,011,000	43,437,000	42,082,000	40,515,000	35,961,000	33,190,000	28,393,000	25,713,000	23,992,000	16,436,000	13,619,000	11,206,000	10,411,000	9,597,000	8,192,000	6,961,000	5,871,000
general and administrative	24,879,000	21,451,000	29,731,000	19,204,000	16,941,000	14,434,000	13,165,000	12,389,000	9,630,000	9,265,000	8,626,000	7,226,000	6,631,000	5,610,000	5,398,000	6,224,000	4,450,000	3,437,000	3,245,000	3,001,000
total operating expenses	134,381,000	117,884,000	123,298,000	100,186,000	84,101,000	76,693,000	74,440,000	65,369,000	57,537,000	51,393,000	46,154,000	41,495,000	32,111,000	27,120,000	24,705,000	28,525,000	29,675,000	24,398,000	21,265,000	19,428,000
income from operations	43,282,000	43,623,000	32,374,000	39,814,000	42,423,000	36,763,000	29,576,000	15,372,000	13,983,000	2,813,000	-180,000	-17,487,000	-15,866,000	-12,807,000	-18,011,000	-18,979,000	-15,363,000	-13,065,000	-11,253,000	-12,159,000
yoy	2.02%	18.66%	9.46%	159.00%	203.39%	1206.90%	-16531.11%	-187.91%	-188.13%	-121.96%	-99.00%	-7.86%	3.27%	-1.97%	60.06%	56.09%
qoq	-0.78%	34.75%	-18.69%	-6.15%	15.40%	24.30%	92.40%	9.93%	397.08%	-1662.78%	-98.97%	10.22%	23.89%	-28.89%	-5.10%	23.54%	17.59%	16.10%	-7.45%
operating margin %	21.32%	23.45%	17.97%	24.72%	29.46%	27.99%	24.49%	16.42%	16.61%	4.32%	-0.32%	-54.82%	-69.85%	-65.38%	-175.10%	-124.89%	-107.34%	-115.28%	-112.40%	-167.27%
income from equity method investment	-167,000	-733,000	-146,000	-823,000	-1,061,000	97,000	-1,464,000
interest expense	-2,950,000	-2,509,000	-810,000	-636,000	-969,000	-316,000	-304,000	-297,000	-301,000	-165,000	-318,000	-312,000	-315,000	-314,000	-306,000	-277,000	-198,000	-251,000	-250,000	-245,000
other income	15,295,000	4,699,000	1,586,000	2,382,000	4,261,000	-1,423,000	-1,473,000	-310,000	-213,000	-280,000	146,000	-235,000	314,000	218,000	220,000	504,000	827,000	385,000	913,000	221,000
net income before taxes	55,460,000	45,080,000	33,004,000	40,737,000	44,654,000	35,121,000	26,335,000	14,718,000	13,048,000	2,026,000	-352,000	-23,557,000	-15,867,000	-12,903,000	-18,097,000	-18,752,000	-14,734,000	-12,931,000	-10,590,000	-12,792,000
income tax provision	3,962,000	10,094,000	4,142,000	1,612,000	272,250	118,000	774,000	197,000	106,000	78,000	73,000	44,000	7,000	29,000	21,000	23,000	11,000	26,000	18,000	7,000
net income	44,305,000	34,986,000	28,862,000	39,125,000	140,911,000	35,003,000	25,561,000	14,521,000	12,942,000	1,948,000	-425,000	-23,601,000	-15,874,000	-12,932,000	-18,118,000	-18,775,000	-14,745,000	-12,957,000	-10,608,000	-12,799,000
yoy	-68.56%	-0.05%	12.91%	169.44%	988.79%	1696.87%	-6114.35%	-161.53%	-181.53%	-115.06%	-97.65%	25.70%	7.66%	-0.19%	70.80%	46.69%
qoq	26.64%	21.22%	-26.23%	-72.23%	302.57%	36.94%	76.03%	12.20%	564.37%	-558.35%	-98.20%	48.68%	22.75%	-28.62%	-3.50%	27.33%	13.80%	22.14%	-17.12%
net income margin %	21.83%	18.81%	16.02%	24.29%	97.84%	26.65%	21.17%	15.51%	15.37%	2.99%	-0.76%	-73.98%	-69.88%	-66.01%	-176.14%	-123.54%	-103.03%	-114.33%	-105.95%	-176.08%
unrealized gain on available-for-sale securities	180,750	242,000	-24,000	505,000			-320,000	-815,000				7,000				68,000	-22,000	-18,000	75,000
adjustment for net gain realized and included in other income				-5,000										-21,000
total comprehensive income	44,747,000	35,228,000	28,838,000	39,625,000	141,656,000	34,728,000	25,241,000	13,706,000	-5,523,500	1,931,000
net income per share											-0.01	-0.68	-0.46	-0.38	-0.56	-0.59	-0.48	-0.46	-0.38	-1.37
basic	1.2	0.95	0.79	1.07	3.92	0.97	0.71	0.41	-0.158	0.06
diluted	1.15	0.92	0.76	1.03	3.71	0.92	0.68	0.39	-0.158	0.05
shares used in computing net income per share
basic	75,485	36,797,072	36,663,327	36,427,263	93,474	36,003,931	35,825,947	35,587,337	8,753,268	35,207,276
diluted	21,970	38,196,780	38,226,153	37,979,448	68,483	37,948,049	37,690,094	37,623,477	8,753,268	37,567,176
unrealized loss on available-for-sale securities					-352,500	-275,000
share in net income of equity method investment								-47,000	-421,000	-342,000		-5,523,000
other comprehensive income:
unrealized gain/(loss) on available-for-sale securities									-4,000	-17,000	-6,000		-3,500		-82,000
total other comprehensive income									-4,000	-17,000			-8,750	-21,000
total comprehensive loss											-431,000	-23,594,000	-15,865,000	-12,953,000	-18,200,000	-18,707,000	-14,767,000	-12,975,000	-10,533,000	-12,799,000
net income per share											-0.01	-0.68	-0.46	-0.38	-0.56	-0.59	-0.48	-0.46	-0.38	-1.37
shares used in computing net income per share, basic and diluted											35,030,036	34,797,400	456,380	34,078,726	32,156,476	31,644,041	2,018,432	28,085,821	28,002,887	9,364,755
change in fair value of warrant liability																				-609,000

We provide you with 20 years income statements for ShockWave Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ShockWave Medical stock. Explore the full financial landscape of ShockWave Medical stock with our expertly curated income statements.

The information provided in this report about ShockWave Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.